Showing BioInteractions for Omega-3-carboxylic acids (DB09568)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
Interacting Group | Interacting Drugs | |
---|---|---|
Omega-3-carboxylic acids is a Diacylglycerol O-acyltransferase 2 antagonist | ||
1 | Diacylglycerol O-acyltransferase 2 inhibitors | Inositol nicotinate |
2 | Diacylglycerol O-acyltransferase 2 agonists | Fish oil |
Interacting Group | Interacting Drugs | |
---|---|---|
Omega-3-carboxylic acids is a 3-hydroxyacyl-CoA dehydrogenase type-2 potentiator |
Interacting Group | Interacting Drugs | |
---|---|---|
Omega-3-carboxylic acids is a Enoyl-CoA hydratase, mitochondrial potentiator |
Interacting Group | Interacting Drugs | |
---|---|---|
Omega-3-carboxylic acids is a Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial potentiator |
Interacting Group | Interacting Drugs | |
---|---|---|
Omega-3-carboxylic acids is a Elongation of very long chain fatty acids protein 4 potentiator | ||
1 | Elongation of very long chain fatty acids protein 4 substrates | Vayarin |
Interacting Group | Interacting Drugs | |
---|---|---|
Omega-3-carboxylic acids is a Lipoprotein lipase stimulator | ||
1 | Lipoprotein lipase inhibitors | Semaglutide, Tyloxapol |
2 | Lipoprotein lipase inducers | Glycyrrhizic acid |
Interacting Group | Interacting Drugs | |
---|---|---|
Omega-3-carboxylic acids is a Cytochrome P450 3A Subfamily substrate | ||
1 | Cytochrome P450 3A Subfamily inhibitors | Crizotinib, Diacerein, Fluvoxamine, Glecaprevir, Istradefylline, Lemborexant, Lonafarnib, Lopinavir, Lorlatinib, Midostaurin, Nefazodone, Olanzapine, Phenelzine, Pibrentasvir, Remoxipride, Rhein, Risdiplam, Selpercatinib |
2 | Cytochrome P450 3A Subfamily substrates | Acalabrutinib, Ambroxol acefyllinate, Budesonide, Dolutegravir, Elagolix, Ethosuximide, Foretinib, Glecaprevir, Lonafarnib, Lorlatinib, Loxoprofen, Mebendazole, Methylprednisolone, Midostaurin, Mirodenafil, Moxisylyte, Naldemedine, Relugolix, Tazemetostat, Thiopental, Tucatinib, Zanubrutinib |
3 | Cytochrome P450 3A Subfamily inducers | Brigatinib, Budesonide, Lemborexant, Methylprednisolone, Midostaurin, Myrrh, Prednisolone phosphate, Prednisone, Relugolix, Rifapentine |
Interacting Group | Interacting Drugs | |
---|---|---|
Omega-3-carboxylic acids is a Leukotriene-B(4) omega-hydroxylase 1 substrate | ||
1 | Leukotriene-B(4) omega-hydroxylase 1 substrates | alpha-Tocopherol acetate, Fingolimod, Florbetaben F-18, Tocofersolan, Tocopherol |
2 | Leukotriene-B(4) omega-hydroxylase 1 inducers | Fingolimod |
3 | Leukotriene-B(4) omega-hydroxylase 1 inhibitors | Ketoconazole |